Screener
Denali Therapeutics Inc. DNLI Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Denali Therapeutics Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
FAQ
- What is Denali Therapeutics Inc.'s book value per share?
- Denali Therapeutics Inc. (DNLI) reported book value per share of $4.46 in Q2 2026.
- How has Denali Therapeutics Inc.'s book value per share changed year-over-year?
- Denali Therapeutics Inc.'s book value per share decreased by 25.6% year-over-year, from $5.99 to $4.46.
- What is the long-term trend for Denali Therapeutics Inc.'s book value per share?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s book value per share has grown at a -10.5% compound annual growth rate (CAGR), from $10.21 to $5.87.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Denali Therapeutics Inc.'s book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude